Reduction of ischemic stroke in rat brain by alpha melanocyte stimulating hormone

Neuropeptides

Volumn 42, Issue 3, 2008, Pages 331-338

  Chen, Gang ^a   Frøkiær, Jørgen ^a   Pedersen, Michael ^a   Nielsen, Søren ^a   Si, Zhichao ^a   Pang, Qi ^b   Stødkilde Jørgensen, Hans ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b SHANDONG UNIVERSITY   (China)

Author keywords

Alpha melanocyte stimulating hormone; Brain ischemia; Diffusion; Magnetic resonance imaging

Indexed keywords

ALPHA INTERMEDIN; SODIUM CHLORIDE; TRIPHENYLTETRAZOLIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; BRAIN INFARCTION SIZE; CEREBROVASCULAR ACCIDENT; COMPARATIVE STUDY; CONTROL GROUP; CONTROLLED STUDY; DIFFUSION COEFFICIENT; DRUG EFFECT; HISTOLOGY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAT; STAINING; STATISTICAL SIGNIFICANCE; VOLUMETRY; WISTAR RAT;

ALPHA-MSH; ANIMALS; BRAIN; BRAIN ISCHEMIA; INFARCTION, MIDDLE CEREBRAL ARTERY; MAGNETIC RESONANCE IMAGING; MALE; RATS; RATS, WISTAR; STROKE; TETRAZOLIUM SALTS;

RATTUS; RATTUS NORVEGICUS;

EID: 44649086433     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.npep.2008.01.004     Document Type: Article

References (39)

1. Avery S., Crockard H.A., and Russell R.R. Evolution and resolution of oedema following severe temporary cerebral ischaemia in the gerbil. J. Neurol. Neurosurg. Psychiatry 47 (1984) 604-610
2. Barone F.C., and Feuerstein G.Z. Inflammatory mediators and stroke: new opportunities for novel therapeutics. J. Cereb. Blood Flow Metab. 19 (1999) 819-834
3. Betz A.L., Iannotti F., and Hoff J.T. Brain edema: a classification based on blood-brain barrier integrity. Cerebrovasc. Brain Metab. Rev. 1 (1989) 133-154
4. Catania A., Gatti S., Colombo G., and Lipton J.M. Targeting melanocortin receptors as a novel strategy to control inflammation. Pharmacol. Rev. 56 (2004) 1-29
5. Dijkhuizen R.M., and Nicolay K. Magnetic resonance imaging in experimental models of brain disorders. J. Cereb. Blood Flow Metab. 23 (2003) 1383-1402
6. Fagan S.C., Hess D.C., Hohnadel E.J., Pollock D.M., and Ergul A. Targets for vascular protection after acute ischemic stroke. Stroke 35 (2004) 2220-2225
7. Feuerstein G.Z., Wang X., and Barone F.C. The role of cytokines in the neuropathology of stroke and neurotrauma. Neuroimmunomodulation 5 (1998) 143-159
8. Forslin A.S., Spulber S., Popescu L.M., Winblad B., Post C., Oprica M., and Schultzberg M. Alpha-melanocyte-stimulating hormone is neuroprotective in rat global cerebral ischemia. Neuropeptides 40 (2006) 65-75
9. Giuliani D., Leone S., Mioni C., Bazzani C., Zaffe D., Botticelli A.R., Altavilla D., Galantucci M., Minutoli L., Bitto A., Squadrito F., and Guarini S. Broad therapeutic treatment window of [Nle(4), D-Phe(7)]alpha-melanocyte-stimulating hormone for long-lasting protection against ischemic stroke, in Mongolian gerbils. Eur. J. Pharmacol. 538 (2006) 48-56
10. Giuliani D., Mioni C., Altavilla D., Leone S., Bazzani C., Minutoli L., Bitto A., Cainazzo M.M., Marini H., Zaffe D., Botticelli A.R., Pizzala R., Savio M., Necchi D., Schioth H.B., Bertolini A., Squadrito F., and Guarini S. Both early and delayed treatment with melanocortin 4 receptor-stimulating melanocortins produces neuroprotection in cerebral ischemia. Endocrinology 147 (2006) 1126-1135
11. Giuliani D., Ottani A., Mioni C., Bazzani C., Galantucci M., Minutoli L., Bitto A., Zaffe D., Botticelli A.R., Squadrito F., and Guarini S. Neuroprotection in focal cerebral ischemia owing to delayed treatment with melanocortins. Eur. J. Pharmacol. (2007)
12. Guarini S., Cainazzo M.M., Giuliani D., Mioni C., Altavilla D., Marini H., Bigiani A., Ghiaroni V., Passaniti M., Leone S., Bazzani C., Caputi A.P., Squadrito F., and Bertolini A. Adrenocorticotropin reverses hemorrhagic shock in anesthetized rats through the rapid activation of a vagal anti-inflammatory pathway. Cardiovasc. Res. 63 (2004) 357-365
13. Hossmann K.A. Pathophysiology and therapy of experimental stroke. Cell Mol. Neurobiol. 26 (2006) 1057-1083
14. Hossmann K.A., Fischer M., Bockhorst K., and Hoehn-Berlage M. NMR imaging of the apparent diffusion coefficient (ADC) for the evaluation of metabolic suppression and recovery after prolonged cerebral ischemia. J. Cereb. Blood Flow Metab. 14 (1994) 723-731
15. Huang J., Upadhyay U.M., and Tamargo R.J. Inflammation in stroke and focal cerebral ischemia. Surg. Neurol. 66 (2006) 232-245
16. Huang Q., and Tatro J.B. Alpha-melanocyte stimulating hormone suppresses intracerebral tumor necrosis factor-alpha and interleukin-1beta gene expression following transient cerebral ischemia in mice. Neurosci. Lett. 334 (2002) 186-190
17. Huh S.K., Lipton J.M., and Batjer H.H. The protective effects of alpha-melanocyte stimulating hormone on canine brain stem ischemia. Neurosurgery 40 (1997) 132-139
18. Kelsen J., Kjaer K., Chen G., Pedersen M., Rohl L., Frokiaer J., Nielsen S., Nyengaard J.R., and Ronn L.C. Parecoxib is neuroprotective in spontaneously hypertensive rats after transient middle cerebral artery occlusion: a divided treatment response?. J. Neuroinflammation 3 (2006) 31
19. Lipton J.M., and Catania A. Mechanisms of antiinflammatory action of the neuroimmunomodulatory peptide alpha-MSH. Ann. N.Y. Acad. Sci. 840 (1998) 373-380
20. Liu T., Clark R.K., McDonnell P.C., Young P.R., White R.F., Barone F.C., and Feuerstein G.Z. Tumor necrosis factor-alpha expression in ischemic neurons. Stroke 25 (1994) 1481-1488
21. Loddick S.A., and Rothwell N.J. Neuroprotective effects of human recombinant interleukin-1 receptor antagonist in focal cerebral ischaemia in the rat. J. Cereb. Blood Flow Metab. 16 (1996) 932-940
22. Minami M., Kuraishi Y., Yabuuchi K., Yamazaki A., and Satoh M. Induction of interleukin-1 beta mRNA in rat brain after transient forebrain ischemia. J. Neurochem. 58 (1992) 390-392
23. Muir K.W., Buchan A., von K.R., Rother J., and Baron J.C. Imaging of acute stroke. Lancet Neurol. 5 (2006) 755-768
24. Ordidge R., Thornton J., Clemence M., Punwani S., Cady E., Penrice J., Amess P., and Wyatt J. NMR studies of hypoxic-ischaemic injury in neonatal brain using imaging and spectroscopy. Adv. Exp. Med. Biol. 428 (1997) 539-544
25. Pinteaux E., Rothwell N.J., and Boutin H. Neuroprotective actions of endogenous interleukin-1 receptor antagonist (IL-1ra) are mediated by glia. Glia 53 (2006) 551-556
26. + - adenosine triphosphatase and cytochrome oxidase activity. Radiology 223 (2002) 65-75
27. Relton J.K., and Rothwell N.J. Interleukin-1 receptor antagonist inhibits ischaemic and excitotoxic neuronal damage in the rat. Brain Res. Bull. 29 (1992) 243-246
28. Rothwell N.J., and Relton J.K. Involvement of interleukin-1 and lipocortin-1 in ischaemic brain damage. Cerebrovasc. Brain Metab. Rev. 5 (1993) 178-198
29. Schuier F.J., and Hossmann K.A. Experimental brain infarcts in cats. II. Ischemic brain edema. Stroke 11 (1980) 593-601
30. Stamatovic S.M., Dimitrijevic O.B., Keep R.F., and Andjelkovic A.V. Inflammation and brain edema: new insights into the role of chemokines and their receptors. Acta Neurochir. Suppl. 96 (2006) 444-450
31. Tuor U.I., Kozlowski P., Del Bigio M.R., Ramjiawan B., Su S., Malisza K., and Saunders J.K. Diffusion- and T2-weighted increases in magnetic resonance images of immature brain during hypoxia-ischemia: transient reversal posthypoxia. Exp. Neurol. 150 (1998) 321-328
32. Unterberg A.W., Stover J., Kress B., and Kiening K.L. Edema and brain trauma. Neuroscience 129 (2004) 1021-1029
33. Van B.N., Roberts T.P., and Cremer J.E. The application of magnetic resonance imaging to the study of experimental cerebral ischaemia. Cerebrovasc. Brain Metab. Rev. 6 (1994) 180-210
34. Wikberg J.E., Muceniece R., Mandrika I., Prusis P., Lindblom J., Post C., and Skottner A. New aspects on the melanocortins and their receptors. Pharmacol. Res. 42 (2000) 393-420
35. Williams A.J., Berti R., Dave J.R., Elliot P.J., Adams J., and Tortella F.C. Delayed treatment of ischemia/reperfusion brain injury: extended therapeutic window with the proteosome inhibitor MLN519. Stroke 35 (2004) 1186-1191
36. Yabuuchi K., Minami M., Katsumata S., Yamazaki A., and Satoh M. An in situ hybridization study on interleukin-1 beta mRNA induced by transient forebrain ischemia in the rat brain. Brain Res. Mol. Brain Res. 26 (1994) 135-142
37. Yamasaki Y., Matsuura N., Shozuhara H., Onodera H., Itoyama Y., and Kogure K. Interleukin-1 as a pathogenetic mediator of ischemic brain damage in rats. Stroke 26 (1995) 676-680
38. Zaremba J., Skrobanski P., and Losy J. Tumour necrosis factor-alpha is increased in the cerebrospinal fluid and serum of ischaemic stroke patients and correlates with the volume of evolving brain infarct. Biomed. Pharmacother. 55 (2001) 258-263
39. Zheng Z., and Yenari M.A. Post-ischemic inflammation: molecular mechanisms and therapeutic implications. Neurol. Res. 26 (2004) 884-892